Skip to main content
Erschienen in: Aesthetic Plastic Surgery 1/2018

08.08.2017 | Original Article

Keloid Skin Flap Retention and Resurfacing in Facial Keloid Treatment

verfasst von: Shu Liu, Weizhong Liang, Kexin Song, Youbin Wang

Erschienen in: Aesthetic Plastic Surgery | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

Facial keloids commonly occur in young patients. Multiple keloid masses often converge into a large lesion on the face, representing a significant obstacle to keloid mass excision and reconstruction. We describe a new surgical method that excises the keloid mass and resurfaces the wound by saving the keloid skin as a skin flap during facial keloid treatment.

Methods

Forty-five patients with facial keloids were treated in our department between January 2013 and January 2016. Multiple incisions were made along the facial esthetic line on the keloid mass. The keloid skin was dissected and elevated as a skin flap with one or two pedicles. The scar tissue in the keloid was then removed through the incision. The wound was covered with the preserved keloid skin flap and closed without tension. Radiotherapy and hyperbaric oxygen were applied after surgery. Patients underwent follow-up examinations 6 and 12 months after surgery.

Results

Of the 45 total patients, 32 patients were cured and seven patients were partially cured. The efficacy rate was 88.9%, and 38 patients (84.4%) were satisfied with the esthetic result.

Conclusion

We describe an efficacious and esthetically satisfactory surgical method for managing facial keloids by preserving the keloid skin as a skin flap.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wolfram D, Tzankov A, Pülzl P et al (2009) Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35:171–181CrossRefPubMed Wolfram D, Tzankov A, Pülzl P et al (2009) Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35:171–181CrossRefPubMed
2.
3.
Zurück zum Zitat Lindsey WH, Davis PT (1997) Facial keloids. A 15-year experience. Arch Otolaryngol Head Neck Surg 123(4):397–400CrossRefPubMed Lindsey WH, Davis PT (1997) Facial keloids. A 15-year experience. Arch Otolaryngol Head Neck Surg 123(4):397–400CrossRefPubMed
4.
Zurück zum Zitat Donkor P (2007) Head and neck keloid: treatment by core excision and delayed intralesional injection of steroid. J Oral Maxillofac Surg 65(7):1292–1296CrossRefPubMed Donkor P (2007) Head and neck keloid: treatment by core excision and delayed intralesional injection of steroid. J Oral Maxillofac Surg 65(7):1292–1296CrossRefPubMed
5.
Zurück zum Zitat Lee Y, Minn KW, Baek RM et al (2001) A new surgical treatment of keloid: keloid core excision. Ann Plast Surg 46(2):135–140CrossRefPubMed Lee Y, Minn KW, Baek RM et al (2001) A new surgical treatment of keloid: keloid core excision. Ann Plast Surg 46(2):135–140CrossRefPubMed
6.
Zurück zum Zitat Pestarardo CM, Cordero A Jr, Ansorena JM et al (1995) Acne keloidalis nuchae. Tissue expansion treatment. Dermatol Surg 21(8):723–724CrossRef Pestarardo CM, Cordero A Jr, Ansorena JM et al (1995) Acne keloidalis nuchae. Tissue expansion treatment. Dermatol Surg 21(8):723–724CrossRef
7.
Zurück zum Zitat Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43:S3–S18CrossRefPubMed Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43:S3–S18CrossRefPubMed
8.
Zurück zum Zitat Gauglitz GG, Korting HC, Pavicic T et al (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17(1–2):113–125PubMed Gauglitz GG, Korting HC, Pavicic T et al (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17(1–2):113–125PubMed
9.
Zurück zum Zitat Jacobsson F (1948) The treatment of keloid at radium-hemmet, 1921–1941. Acta Radiol 29(3):251–267CrossRefPubMed Jacobsson F (1948) The treatment of keloid at radium-hemmet, 1921–1941. Acta Radiol 29(3):251–267CrossRefPubMed
10.
Zurück zum Zitat Speranza G, Sultanem K, Muanza T (2008) Descriptive study of patients receiving excision and radiotherapy for keloids. Int J Radiat Oncol Biol Phys 71(5):1465–1469CrossRefPubMed Speranza G, Sultanem K, Muanza T (2008) Descriptive study of patients receiving excision and radiotherapy for keloids. Int J Radiat Oncol Biol Phys 71(5):1465–1469CrossRefPubMed
11.
Zurück zum Zitat Malaker K, Vijayraghavan K, Hodson I et al (2004) Retrospective analysis of treatment of unresectable keloids with primary radiation over 25 years. Clin Oncol (R Coll Radiol) 16(4):290–298CrossRef Malaker K, Vijayraghavan K, Hodson I et al (2004) Retrospective analysis of treatment of unresectable keloids with primary radiation over 25 years. Clin Oncol (R Coll Radiol) 16(4):290–298CrossRef
12.
Zurück zum Zitat Sigaux N, Jacquemart M, Cousin AS et al (2017) Association of surgical excision and brachytherapy for the management of keloids. J Stomatol Oral Maxillofac Surg 118(3):161–166CrossRefPubMed Sigaux N, Jacquemart M, Cousin AS et al (2017) Association of surgical excision and brachytherapy for the management of keloids. J Stomatol Oral Maxillofac Surg 118(3):161–166CrossRefPubMed
13.
Zurück zum Zitat Guix B, Henríquez I, Andrés A et al (2001) Treatment of keloids by high-dose-rate brachytherapy: a seven-year study. Int J Radiat Oncol Biol Phys 50(1):167–172CrossRefPubMed Guix B, Henríquez I, Andrés A et al (2001) Treatment of keloids by high-dose-rate brachytherapy: a seven-year study. Int J Radiat Oncol Biol Phys 50(1):167–172CrossRefPubMed
14.
Zurück zum Zitat Ogawa R, Yoshitatsu S, Yoshida K et al (2009) Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis. Plast Reconstr Surg 124(4):1196–1201CrossRefPubMed Ogawa R, Yoshitatsu S, Yoshida K et al (2009) Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis. Plast Reconstr Surg 124(4):1196–1201CrossRefPubMed
15.
Zurück zum Zitat Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17(1–2):113–125PubMed Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17(1–2):113–125PubMed
16.
Zurück zum Zitat Ogama R, Akaishi S, Chenyu H et al (2011) Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction. J Nippon Med Sch 78:68–76CrossRef Ogama R, Akaishi S, Chenyu H et al (2011) Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction. J Nippon Med Sch 78:68–76CrossRef
17.
Zurück zum Zitat Admas BB, Gloster HM (2002) Surgical pearl: excision with suprakeloidal flap and radiation therapy for keloids. J Am Acad Dermatol 47(2):307–309CrossRef Admas BB, Gloster HM (2002) Surgical pearl: excision with suprakeloidal flap and radiation therapy for keloids. J Am Acad Dermatol 47(2):307–309CrossRef
18.
Zurück zum Zitat Araújo FM, Kondo RN, Minelli L (2013) Pyoderma gangrenosum: skin grafting and hyperbaric oxygen as adjuvants in the treatment of a deep and extensive ulcer. An Bras Dermatol 88:176–178CrossRefPubMedPubMedCentral Araújo FM, Kondo RN, Minelli L (2013) Pyoderma gangrenosum: skin grafting and hyperbaric oxygen as adjuvants in the treatment of a deep and extensive ulcer. An Bras Dermatol 88:176–178CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Migita H, Yoshitake S, Tange Y et al (2016) Hyperbaric oxygen therapy suppresses apoptosis and promotes renal tubular regeneration after renal ischemia reperfusion injury in rats. Nephrourol Mon 8(1):e34421CrossRefPubMedPubMedCentral Migita H, Yoshitake S, Tange Y et al (2016) Hyperbaric oxygen therapy suppresses apoptosis and promotes renal tubular regeneration after renal ischemia reperfusion injury in rats. Nephrourol Mon 8(1):e34421CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Skeik N, Porten BR, Isaacson E et al (2015) Hyperbaric oxygen treatment outcome for different indications from a single center. Ann Vasc Surg 29(2):206–214CrossRefPubMed Skeik N, Porten BR, Isaacson E et al (2015) Hyperbaric oxygen treatment outcome for different indications from a single center. Ann Vasc Surg 29(2):206–214CrossRefPubMed
22.
Zurück zum Zitat Richards L, Lineaweaver WC, Stile F et al (2003) Effect of hyperbaric oxygen therapy on the tube pedicle flap survival in a rat model. Ann Plast Surg 50(1):51–56CrossRefPubMed Richards L, Lineaweaver WC, Stile F et al (2003) Effect of hyperbaric oxygen therapy on the tube pedicle flap survival in a rat model. Ann Plast Surg 50(1):51–56CrossRefPubMed
23.
Zurück zum Zitat Xiao YD, Liu YQ, Li JL et al (2015) Hyperbaric oxygen preconditioning inhibits skin flap apoptosis in a rat ischemia-reperfusion model. J Surg Res 199(2):732–739CrossRefPubMed Xiao YD, Liu YQ, Li JL et al (2015) Hyperbaric oxygen preconditioning inhibits skin flap apoptosis in a rat ischemia-reperfusion model. J Surg Res 199(2):732–739CrossRefPubMed
Metadaten
Titel
Keloid Skin Flap Retention and Resurfacing in Facial Keloid Treatment
verfasst von
Shu Liu
Weizhong Liang
Kexin Song
Youbin Wang
Publikationsdatum
08.08.2017
Verlag
Springer US
Erschienen in
Aesthetic Plastic Surgery / Ausgabe 1/2018
Print ISSN: 0364-216X
Elektronische ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-017-0949-1

Weitere Artikel der Ausgabe 1/2018

Aesthetic Plastic Surgery 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.